SYSTEMIC SCLEROSIS – NISSC-2 non-interventional study – Autologous Hematopoietic Stem Cell Transplantation – Active recruiting continues during period of COVID-19 pandemic for transplanted patients/all patient follow-ups conducted through telemedicine

ClinicalTrials.gov: NCT03444805 Protocol Title: Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional

Read more